Contact Us


Your Name (required)

Your Email (required)

Your Phone (required)

Subject

Interested In... (required)

Your Message

Healthcare 3PL

Case Study: Specialized Solutions Are Business As Usual At WDSrx

How A National Manufacturer Responded Rapidly To Increased Retail Demand INTRODUCTION AND VIDEO CASE STUDY SUCCESS FOR THIRD PARTY LOGISTICS PROVIDERS MEANS INCORPORATING FLEXIBILITY INTO DAILY BUSINESS PRACTICES.   CHALLENGE Versatility was applied when a national nutritional supplement manufacturer approached WDSrx about a product display program for the U.S. store locations of a global consumer goods retailer.  The scope of this project involved multiple deliverables and extensive coord...

Case Study: Distributor of Veterinary Medications Seeking Efficiency Finds Their Forever Home With WDSrx

A leading distributor of human crossover medications for veterinary use managed storage and distribution of thousands of products from a small office at their headquarters location in Miami, FL.  As their business grew, demands increased for labor and time that distracted the company from core marketing and sales operations.  After extensive research and an RFP review, WDSrx, a pharmaceutical 3PL, was selected and developed the preferred solution to increase efficiency and allow the client com...

SMOOTH SAILING FOR IMPORTING CONTROLLED SUBSTANCES (CII-CV) INTO THE UNITED STATES

SMOOTH SAILING FOR IMPORTING CONTROLLED SUBSTANCES (CII-CV) INTO THE UNITED STATES Boca Raton, FL (August 9, 2016) – Over $86 billion in pharmaceutical products were imported into the United States in 2015. Third Party Logistics providers like WDSrx based in Boca Raton, FL specialize in delivering drug products to their final destination while complying with strict government regulations. To facilitate client transportation needs around the world, WDSrx is licensed by the Federal Drug Enforcem...

WDSrx IMPLEMENTS DSCSA PHARMACEUTICAL 3PL COMPLIANCE PRIOR TO FDA DEADLINE

Pharmaceutical 3PL Provider Selects ROC IT, TraceLink and Optel Vision For DSCSA Implementation Boca Raton, FL (August 22, 2016)  — WDSrx, a pharmaceutical 3PL provider based in Boca Raton, FL selected ROC IT, TraceLink and Optel Vision to assist with the transition to comply with requirements in the Drug Supply Chain Security Act (DSCSA).  The law requires all companies within the pharmaceutical supply chain to develop an electronic system designed to increase patient safety by minimizi...

WDSrx SUGAR LAND, TX FACILITY APPROVED FOR VAWD ACCREDITATION

December 8, 2016, Sugar Land, TX — The National Association of Boards of Pharmacy, a national organization of State Boards of Pharmacy that helps ensure public health and safety, approved VAWD accreditation today for the WDSrx facility in Sugar Land, TX, which became operational in December, 2015.  The WDSrx Boca Raton, FL facility received VAWD accreditation in 2011. VAWD-recognized facilities play an important role in preventing counterfeit drugs from entering the United States pharmace...

WDSrx Featured In TAPinto New Brunswick

Following the announcement of our additional facility opening in South Brunswick, New Jersey, WDSrx was featured on the TAPinto New Brunswick Website. Read the article here. TAPinto.net covers more than 100 towns in New Jersey and New York and is accredited by the New Jersey Press Association. The site has over 6,000,000 absolute unique users and is growing rapidly....

Advance – The Official Newsletter Of WDSrx (2nd Edition Q4 2016)

Leadership Letter Adam Runsdorf, President The pharmaceutical Third Party Logistics industry is undergoing significant change. The way we choose to address these changes is the difference between facing challenges or creating opportunities. This issue of Advance focuses on our plans to comply with new rules that are part of the Drug Supply Chain and Security Act, or DSCSA.  The law, signed in 2014, requires that all prescription drug products down to the smallest saleable unit (SSU) be electron...

Are any Controlled Substances (CII) included in your return? If so, please press "Yes" and complete the DEA 222 Request Form. You can also contact Jason Solomon at jsolomon@wdsrx.com or (561) 998-3885 x316.